In general— The Director of the National Institute of Allergy and Infectious Diseases shall conduct or support comprehensive research for the creation of a universal influenza vaccine.
Authorization of appropriations— To carry out this section, there are authorized to be appropriated $200,000,000 for each of fiscal years 2020 through 2024.